Sativa Wellness Group #SWEL, the UK-based CBD business give London South East an operational update Watch Now

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4d Pharma Plc Share News (DDDD)

Share Price Information for 4d Pharma Plc (DDDD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 108.50
Bid: 106.50
Ask: 107.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.94%)
Open: 113.00
High: 114.00
Low: 105.50
Yest. Close: 116.00
DDDD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

IN BRIEF: 4D Pharma Proposes Merger With Longevity Acquisition

IN BRIEF: 4D Pharma Proposes Merger With Longevity Acquisition

22 Oct 20 15:42

UK WINNERS & LOSERS SUMMARY: Shaftesbury Down 13% Amid Fundraise Plans

UK WINNERS & LOSERS SUMMARY: Shaftesbury Down 13% Amid Fundraise Plans

22 Oct 20 11:06

4D Pharma Reports Positive Results From Bowel Syndrome Treatment Trial

4D Pharma Reports Positive Results From Bowel Syndrome Treatment Trial

7 Oct 20 11:25

IN BRIEF: 4D Pharma Interim Loss Widens On R&D Costs Increase

IN BRIEF: 4D Pharma Interim Loss Widens On R&D Costs Increase

30 Sep 20 12:04

UK EXECUTIVE CHANGE SUMMARY: Primorus Adds Three Directors To Board

UK EXECUTIVE CHANGE SUMMARY: Primorus Adds Three Directors To Board

23 Sep 20 19:22

UK WINNERS & LOSERS SUMMARY: Provident Financial Up On Better Outlook

UK WINNERS & LOSERS SUMMARY: Provident Financial Up On Better Outlook

26 Aug 20 10:40

4D Pharma Says Results In MRx0518, Keytruda Cancer Trial "Encouraging"

4D Pharma Says Results In MRx0518, Keytruda Cancer Trial "Encouraging"

26 Aug 20 09:41

UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech

UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech

13 Jul 20 18:25

4D Pharma To Raise GBP7.7 Million In Share Issue, Eyes US Listing

4D Pharma To Raise GBP7.7 Million In Share Issue, Eyes US Listing

13 Jul 20 14:39

Next part of tumour trial begins for 4D Pharma

(Sharecast News) - Biotherapeutics developer 4D Pharma has begin the treatment of the first patients in part B of its phase 1 and 2 clinical trial of 'MRx0518' in combination with immune checkpoint inhibitor 'Keytruda', or pembrolizumab, it announced on Monday, in patients with acquired resistance to prior immune checkpoint therapy.

6 Jul 20 12:38

4D Pharma Starts Treatment Of Patients In Phase 2 Of MRx0518 Trial

4D Pharma Starts Treatment Of Patients In Phase 2 Of MRx0518 Trial

6 Jul 20 10:17

Patient enrolment begins for 4D's Covid therapy candidate

(Sharecast News) - Biotherapeutics-focussed pharmaceutical company 4D Pharma announced on Thursday that its phase 2 clinical trial of the oral immunomodulator 'MRx-4DP0004', for patients hospitalised with Covid-19, was now open to enrolment, with dosing of the first patients expected shortly.

2 Jul 20 12:14

4d Pharma Starts Covid-19 Patients Enrollment For MRx-4DP0004 Study

4d Pharma Starts Covid-19 Patients Enrollment For MRx-4DP0004 Study

2 Jul 20 09:16

4d Pharma Reports Revenue For 2019 But Loss Widens On Higher Costs

4d Pharma Reports Revenue For 2019 But Loss Widens On Higher Costs

26 May 20 10:06

4D Pharma Completes First Part Of Clinical Trial For Cancer Treatment

4D Pharma Completes First Part Of Clinical Trial For Cancer Treatment

11 May 20 10:45

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.